Skip to main content

Table 3 Association between MIAT, H19, and NRON levels with clinical parameters in MS patients: using univariate and multiple linear regression models

From: Expression and diagnostic values of MIAT, H19, and NRON long non-coding RNAs in multiple sclerosis patients

Characteristics

Univariate

Multiplevariate *

Beta

95% CI

P Value

Beta

95% CI

P Value

MIAT relative expression (log2)

Female sex

0.21

 − 0.78, 1.19

0.681

0.38

 − 0.58, 1.33

0.436

 > 30 age-old

0.16

 − 0.744, 1.06

0.731

0.28

 − 0.61, 1.17

0.530

Type MS (SP vs. RR)

1.45

0.60, 2.29

0.001

1.48

0.62, 2.35

0.001

Severity MS (≥ 0.5 vs. < 0.5)

 − 0.28

 − 1.02, 0.46

0.462

 − 0.16

 − 0.89, 0.57

0.664

H19 relative expression (log2)

Female sex

2.41

0.86, 3.96

0.003

2.76

1.25, 4.28

0.001

 > 30 age-old

0.79

 − 0.69, 2.26

0.291

1.34

 − 0.07, 2.75

0.063

Type MS (SP vs. RR)

1.62

0.17, 3.07

0.028

1.92

0.54, 3.29

0.007

Severity MS (≥ 0.5 vs. < 0.5)

 − 0.11

 − 1.33, 1.12

0.846

0.14

 − 1.01, 1.29

0.809

NRON relative expression (log2)

Female sex

0.63

 − 0.51, 1.77

0.276

0.57

 − 0.55, 1.69

0.314

 > 30 age-old

0.39

 − 0.66, 1.43

0.463

0.28

 − 0.76, 1.32

0.594

Type MS (RR vs. SP)

1.53

0.53, 2.53

0.003

1.49

0.48, 2.51

0.004

Severity MS (≥ 0.5 vs. < 0.5)

 − 0.20

 − 1.06, 0.66

0.640

 − 0.25

 − 1.10, 0.59

0.556